Segment Information - Results and Reconciliation of Operating Loss to Adjusted EBITDA (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Oct. 03, 2025 |
Sep. 27, 2024 |
Oct. 03, 2025 |
Sep. 27, 2024 |
Dec. 31, 2024 |
|
| Segment Reporting Information [Line Items] | |||||
| Net sales | $ 548,912 | $ 505,222 | $ 1,672,291 | $ 1,546,648 | |
| Cost of Goods and Services Sold | 219,999 | 218,763 | 676,452 | 673,410 | |
| Research and development expense | 29,739 | 20,491 | 88,967 | 67,347 | |
| Adjusted EBITDA (non-GAAP) | 94,768 | 90,203 | 291,092 | 263,651 | |
| Net Loss (GAAP) | (570,913) | (31,262) | (663,166) | (121,615) | |
| Income (loss) from discontinued operations, net of taxes | 40 | (2,243) | 258 | (2,175) | |
| Income tax expense (benefit) | 4,005 | (9,096) | 13,037 | (25,408) | |
| Restructuring charges | 3,376 | 7,786 | 8,204 | 25,284 | |
| MDR and other costs | 2,426 | 5,297 | 8,985 | 14,757 | |
| Strategic transaction costs | 15,675 | 21,428 | 41,180 | 64,958 | |
| Stock-based compensation | 8,957 | 7,827 | 25,032 | 21,868 | |
| Depreciation and other amortization | 30,691 | 28,440 | 88,902 | 85,740 | |
| Amortization of acquired intangibles | 43,689 | 42,786 | 128,463 | 124,653 | |
| Goodwill impairment charge | 548,442 | 0 | 548,442 | 0 | |
| Purchase of royalty interest | 0 | 0 | 45,818 | 0 | |
| Inventory step-up | 0 | 8,376 | 18,119 | 37,361 | |
| Interest expense, net | 8,828 | 11,066 | 27,310 | 48,031 | |
| Other (income) expense, net (4) | (448) | (202) | 508 | (9,803) | |
| Segment Operating Income | 94,768 | 90,203 | 291,092 | 263,651 | |
| Non-recurring charges | 2,100 | 3,500 | 7,600 | 12,300 | |
| Legal fees | 400 | 1,800 | 1,400 | 2,400 | |
| Business exit costs | 400 | 1,300 | 1,300 | 4,200 | |
| Assets | 4,433,367 | 4,433,367 | $ 4,718,777 | ||
| Capital expenditures | 53,491 | 51,189 | 141,122 | 127,522 | |
| Cost of Sales | |||||
| Segment Reporting Information [Line Items] | |||||
| Restructuring charges | 1,500 | 2,700 | 1,700 | 2,700 | |
| LimaCorporate S.p.A. | |||||
| Segment Reporting Information [Line Items] | |||||
| Strategic transaction costs | 9,200 | 17,500 | 28,100 | 55,100 | |
| Non-Lima Acquisitions | |||||
| Segment Reporting Information [Line Items] | |||||
| Strategic transaction costs | 6,100 | 2,600 | 11,800 | 5,700 | |
| Prevention & Recovery | |||||
| Segment Reporting Information [Line Items] | |||||
| Net sales | 290,939 | 274,244 | 854,093 | 811,011 | |
| Cost of Goods and Services Sold | 135,099 | 130,801 | 395,199 | 389,709 | |
| Research and development expense | 9,641 | 9,088 | 28,551 | 27,111 | |
| Other Cost and Expense, Operating | 108,937 | 96,148 | 324,304 | 295,975 | |
| Operating Costs and Expenses | 253,677 | 236,037 | 748,054 | 712,795 | |
| Depreciation | 5,038 | 4,569 | 13,895 | 13,624 | |
| Adjusted EBITDA (non-GAAP) | 42,300 | 42,776 | 119,934 | 111,840 | |
| Segment Operating Income | 42,300 | 42,776 | 119,934 | 111,840 | |
| Assets | 1,770,081 | 1,770,081 | 1,955,138 | ||
| Capital expenditures | 6,860 | 11,028 | 21,195 | 20,596 | |
| Reconstructive | |||||
| Segment Reporting Information [Line Items] | |||||
| Net sales | 257,973 | 230,978 | 818,198 | 735,637 | |
| Cost of Goods and Services Sold | 82,855 | 77,224 | 259,760 | 243,619 | |
| Research and development expense | 20,098 | 11,403 | 60,416 | 40,236 | |
| Other Cost and Expense, Operating | 128,263 | 118,167 | 401,871 | 372,087 | |
| Operating Costs and Expenses | 231,216 | 206,794 | 722,047 | 655,942 | |
| Depreciation | 25,711 | 23,243 | 75,007 | 72,116 | |
| Adjusted EBITDA (non-GAAP) | 52,468 | 47,427 | 171,158 | 151,811 | |
| Segment Operating Income | 52,468 | 47,427 | 171,158 | 151,811 | |
| Assets | 2,663,286 | 2,663,286 | $ 2,763,639 | ||
| Capital expenditures | $ 46,631 | $ 40,161 | $ 119,927 | $ 106,926 | |
| X | ||||||||||
- Definition Inventory Adjustments, Increase (Decrease) No definition available.
|
| X | ||||||||||
- Definition Medical Device Regulations and other Costs No definition available.
|
| X | ||||||||||
- Definition Non-Recurring Medical Device Restructuring Costs No definition available.
|
| X | ||||||||||
- Definition Purchase of Royalty Interest No definition available.
|
| X | ||||||||||
- Definition Restructuring Charges and Other Related Charges No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) for the reportable segment before interest expense and expenses related to major restructuring programs. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs. No definition available.
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Portion of net income (loss) attributable to nonredeemable noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|